Our multiomics offering expands with Alamar Biosciences' NULISAseq™ Immune 340 Panel. Measuring 340 immune and regulatory proteins, the panel complements Nightingale Health's NMR metabolomics platform to provide insights into immunometabolic biology. research.nightingalehealth.com/blog/nightin...
research.nightingalehealth.com
Nightingale Health expands its multiomics offering with Alamar’s NULISAseq Immune 340 Panel